News

Bavarian Nordic has announced an expansion of its strategic collaboration with Serum Institute of India aimed at strengthening global manufacturing capacity for its chikungunya vaccine.…
Read More...

Idorsia Ltd has entered into an exclusive distribution and commercialization agreement with Pharmalink Drug Store L.L.C to bring its insomnia treatment QUVIVIQ™ (daridorexant) to…
Read More...

Vaccine manufacturer CSL Seqirus has announced a long-term partnership with the Pan American Health Organization (PAHO) Regional Revolving Fund aimed at strengthening influenza vaccine…
Read More...

Danish pharmaceutical company Novo Nordisk has announced a new agreement with telehealth platform Hims & Hers Health aimed at expanding patient access to its FDA-approved…
Read More...

The U.S. Food and Drug Administration has approved an expanded indication for Wellcovorin to treat patients with cerebral folate deficiency linked to variants in the Folate Receptor 1…
Read More...

GSK plc has entered into a licensing agreement with Alfasigma S.p.A. granting the Italian pharmaceutical company exclusive global rights to develop, manufacture, and commercialize…
Read More...

The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the development of biosimilar medicines while reducing costs for drug manufacturers…
Read More...

Pharmaceutical company GSK plc has entered into a licensing agreement with Italian drugmaker Alfasigma S.p.A. granting the latter worldwide exclusive rights to develop, manufacture and…
Read More...

Clinical-stage biotechnology company NewcelX Ltd. has announced a collaborative research agreement with immunology-focused firm Eledon Pharmaceuticals aimed at advancing potential new…
Read More...

Biotechnology company Liberate Bio, Inc. has secured new intellectual property licenses aimed at advancing next-generation cell therapies that reprogram immune cells directly inside the…
Read More...

Biotechnology companies Akeso, Inc. and INOVIO have announced a clinical trial collaboration and supply agreement to evaluate a new combination immunotherapy approach for glioblastoma…
Read More...

Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA interference specialist Alnylam Pharmaceuticals aimed at identifying novel…
Read More...

BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility at Flatiron Park in Boulder, marking a significant expansion for the…
Read More...

Affinia Therapeutics has received Fast Track designation from the U.S. Food and Drug Administration for its investigational gene therapy candidate AFTX-201, a potential treatment for…
Read More...

Innovative biotech firm Antengene Corporation Limited has entered into a major global licensing agreement with biopharmaceutical company UCB to advance the development of ATG-201, a…
Read More...

Esperion has announced a definitive agreement to acquire Corstasis Therapeutics in a move aimed at strengthening its cardiovascular portfolio and expanding access to innovative…
Read More...

The Ministry of Health, Labour and Welfare has granted orphan drug designation to rilzabrutinib, an investigational oral therapy, for the treatment of IgG4-related disease (IgG4-RD).…
Read More...

Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in Athlone, Ireland, a move aimed at increasing production capacity for…
Read More...

Biotechnology company Sinopia Biosciences, Inc. has entered into a research collaboration with Japanese pharmaceutical firm Ono Pharmaceutical Co., Ltd. to discover new therapeutic…
Read More...

Quotient Sciences has announced an extended commercial supply partnership with Ipsen to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare and…
Read More...